Novabay Pharmaceuticals Stock Price on May 13, 2022
| NBY Stock | USD 0.08 0.0003 0.39% |
Below is the normalized historical share price chart for NovaBay Pharmaceuticals extending back to October 26, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NovaBay Pharmaceuticals stands at 0.08, as last reported on the 24th of April, with the highest price reaching 0.08 and the lowest price hitting 0.07 during the day.
If you're considering investing in NovaBay Stock, it is important to understand the factors that can impact its price. NovaBay Pharmaceuticals has Sharpe Ratio of -0.14, which conveys that the firm had a -0.14% return per unit of risk over the last 3 months. NovaBay Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NovaBay Pharmaceuticals' Standard Deviation of 5.95, risk adjusted performance of (0.09), and Mean Deviation of 4.31 to check out the risk estimate we provide.
At this time, NovaBay Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 4.4 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 88.5 M in 2024. . Price Earnings To Growth Ratio is likely to rise to 0 in 2024, whereas Price To Sales Ratio is likely to drop 0.06 in 2024. NovaBay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of October 2007 | 200 Day MA 0.3416 | 50 Day MA 0.124 | Beta 2.01 |
NovaBay |
Sharpe Ratio = -0.1419
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NBY |
Estimated Market Risk
| 6.0 actual daily | 53 53% of assets are less volatile |
Expected Return
| -0.85 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average NovaBay Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NovaBay Pharmaceuticals by adding NovaBay Pharmaceuticals to a well-diversified portfolio.
Price Book 1.9948 | Enterprise Value Ebitda (0.89) | Price Sales 0.1848 | Shares Float 29.9 M | Wall Street Target Price 2.6 |
NovaBay Pharmaceuticals Valuation on May 13, 2022
It is possible to determine the worth of NovaBay Pharmaceuticals on a given historical date. On May 13, 2022 NovaBay was worth 0.18 at the beginning of the trading date compared to the closed value of 6.72. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NovaBay Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find NovaBay Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NovaBay Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NovaBay Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.19 | 6.39 | 6.39 | 6.39 | 21,794 | |
05/13/2022 | 0.18 | 1,061 | 6.72 | 6.72 | 27,162 |
| 0.19 | 6.79 | 6.79 | 6.79 | 24,636 |
| Backtest NovaBay Pharmaceuticals | | | NovaBay Pharmaceuticals History | | | NovaBay Pharmaceuticals Valuation | Previous | Next |
NovaBay Pharmaceuticals Trading Date Momentum on May 13, 2022
| On May 16 2022 NovaBay Pharmaceuticals was traded for 6.79 at the closing time. Highest NovaBay Pharmaceuticals's price during the trading hours was 6.79 and the lowest price during the day was 6.79 . The net volume was 24.6 K. The overall trading history on the 16th of May 2022 contributed to the next trading period price jump. The trading delta at closing time to the next next day price was 1.04% . The trading delta at closing time to current price is 97.02% . |
NovaBay Pharmaceuticals Fundamentals Correlations and Trends
By evaluating NovaBay Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NovaBay Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NovaBay financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NovaBay Pharmaceuticals Stock history
NovaBay Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NovaBay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NovaBay Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NovaBay Pharmaceuticals stock prices may prove useful in developing a viable investing in NovaBay Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.2 M | 4.4 M | |
| Net Loss | -14.6 M | -15.4 M |
NovaBay Pharmaceuticals Quarterly Net Working Capital |
|
NovaBay Pharmaceuticals Stock Technical Analysis
NovaBay Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NovaBay Pharmaceuticals Period Price Range
Low | May 13, 2022
| High |
0.18 | 6.72 |
NovaBay Pharmaceuticals April 24, 2024 Market Strength
Market strength indicators help investors to evaluate how NovaBay Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NovaBay Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying NovaBay Pharmaceuticals stock market strength indicators, traders can identify NovaBay Pharmaceuticals entry and exit signals to maximize returns
| Accumulation Distribution | 26990.04 | |||
| Daily Balance Of Power | 0.0062 | |||
| Rate Of Daily Change | 37.33 | |||
| Day Median Price | 534.08 | |||
| Day Typical Price | 358.29 | |||
| Market Facilitation Index | 0.0388 | |||
| Price Action Indicator | (524.08) | |||
| Period Momentum Indicator | (6.64) |
NovaBay Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NovaBay Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of NovaBay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NovaBay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.01) | |||
| Total Risk Alpha | (1.74) | |||
| Treynor Ratio | (1.02) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.Note that the NovaBay Pharmaceuticals information on this page should be used as a complementary analysis to other NovaBay Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for NovaBay Stock analysis
When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is NovaBay Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NovaBay Pharmaceuticals. If investors know NovaBay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NovaBay Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.96) | Revenue Per Share 3.494 | Quarterly Revenue Growth 0.023 | Return On Assets (0.25) | Return On Equity (1.39) |
The market value of NovaBay Pharmaceuticals is measured differently than its book value, which is the value of NovaBay that is recorded on the company's balance sheet. Investors also form their own opinion of NovaBay Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NovaBay Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NovaBay Pharmaceuticals' market value can be influenced by many factors that don't directly affect NovaBay Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NovaBay Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NovaBay Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NovaBay Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.